Thanks for visiting Scientific Computing World.

You're trying to access an editorial feature that is only available to logged in, registered users of Scientific Computing World. Registering is completely free, so why not sign up with us?

By registering, as well as being able to browse all content on the site without further interruption, you'll also have the option to receive our magazine (multiple times a year) and our email newsletters.

Ingenuity Systems extends software agreement with GlaxoSmithKline

Share this on social media:

Ingenuity Systems has extended and expanded its existing license agreement with GlaxoSmithKline for access to Ingenuity Pathways Analysis (IPA) software. 

 

The new agreement enables GSK to provide enterprise-wide IPA access to researchers for rapid assessment of the signalling and metabolic pathways, molecular networks, and biological processes that are most significant to disease targets.  In addition, GSK will also use Ingenuity's content and proprietary algorithms.